TrialPath
Recruiting

Novel Technologies to Improve Echocardiographic Estimates of Left Ventricular Filling Pressure in Heart Failure Combined With Atrial Fibrillation

NCT07436299 · Oslo University Hospital
In plain English

Click the button to translate this study into plain language — what it is, who qualifies, and what participation looks like.

Official title
Novel Technologies to Improve Echocardiographic Estimates of Left Ventricular Filling Pressure in Heart Failure Combined With Atrial Fibrillation: A Prospective Multicenter Study
About this study
Study Design: This is a prospective, multicenter study of atrial fibrillation (AF) patients referred for right or left heart catheterization (RHC/LHC). The primary objective will be to develop and validate a clinically applicable algorithm combining echocardiographic and clinical parameters to differentiate normal from elevated left ventricular (LV) filling pressure (LVFP) in AF with ≥80% diagnostic accuracy. Secondary objectives will be to identify imaging predictors of abnormal pulmonary capillary wedge pressure (PCWP) elevation during exercise and to identify prognostic imaging markers associated with mortality and heart-failure outcomes over a 3-year follow-up period. LVFP will be measured as PCWP during RHC and as LV end-diastolic pressure (LVEDP) during LHC. In cases studied during left atrial (LA) interventions, LA mean pressure will be used as a measure of LVFP. Echocardiography will be performed during, immediately before, or immediately after catheterization (≤8 hours separation, without cardiovascular medication changes). A dedicated exercise substudy will investigate imaging predictors of abnormal PCWP rise during exertion. Recruitment of at least 400 patients is considered feasible based on experience from a previous international multicenter AF study. Patients will be recruited from 15 centers in the USA, Europe, Asia, and New Zealand over a period of 1.5 to 2 years. Data collection: A 12-lead electrocardiogram (ECG) and standard clinical data, including cuff blood pressure and standard blood tests with NT-proBNP, will be recorded. Echocardiographic Imaging: Echocardiographic measurements will be performed according to most recent American Society of Echocardiography / European Association of Cardiovascular Imaging guidelines. In addition, LA and right atrial (RA) strains will be measured. Echocardiographic recordings will be obtained by experienced investigators without knowledge of the invasive data. A core lab for echo analysis will be established. A minimum of 10 consecutive heartbeats will be recorded. Echo will be performed either simultaneously or within 8 hours of hemodynamic assessment. Equipment from different vendors will be used. Three-dimensional echocardiography will be used in selected patients. Key Echocardiographic Views and Measurements * Apical 4-chamber LV-focused: mitral inflow, tissue Doppler early diastolic velocity (e') (septal, lateral, average), systolic velocity (s'), isovolumetric relaxation time, LV global longitudinal strain (GLS), LV volumes and ejection fraction, LV mass * Apical 4-chamber LA-focused: pulmonary vein Doppler (S and D velocities and their velocity-time integrals), LA strain, LA volumes * Apical 5-chamber: aortic valve continuous-wave (CW) Doppler * Apical 2- and 3-chamber: LV GLS, focused LV/LA imaging * Right ventricular / pulmonary artery evaluation: tricuspid regurgitation velocity, right ventricular outflow tract (RVOT) pulsed-wave Doppler, RVOT acceleration time * Subcostal inferior vena cava (IVC) view: IVC diameter and collapsibility. * RA-focused view: RA reservoir strain Cardiac Catheterization: LVFP \>15 mmHg will be considered elevated. LVFP will be averaged over 10 beats during end-expiration, using an index beat approach for selection of heart cycles. Bicycle ergometer in supine position with simultaneous RHC will be performed in patients scheduled for this procedure as part of a diagnostic work-up and will be performed according to current clinical routine. This includes pressure measurements and focused echocardiographic study at rest and at peak exercise. The rate of pedaling will be 60 rotations per minute, and the workload will increase gradually to a moderate level. Outcome Data: All-cause mortality and heart failure hospitalizations will be the primary clinical outcomes. Outcome analysis will be extended to 3 years of follow-up. Data Management and Analysis: All imaging and invasive pressure measurements will be analyzed with investigators blinded to the corresponding data. Echocardiography will be reviewed centrally at the Echo Core Laboratory. Statistical analyses will include descriptive statistics, logistic regression, receiver operating characteristic curve analysis, and supervised machine-learning methods to derive a diagnostic algorithm. A two-sided P value \<0.05 will be considered statistically significant. Study Flowchart: 1\. Screening → 2. Consent → 3. Clinical assessment \& ECG → 4. Echocardiography → 5. RHC/LHC (± exercise) → 6. Data transfer to core labs → 7. Follow-up → 8. Analysis
Eligibility criteria
Inclusion Criteria: * Atrial fibrillation (paroxysmal, persistent, or permanent) * Scheduled for RHC or LHC for clinical reasons * Able to undergo echocardiography and invasive pressure measurement within 8 hours * No cardiovascular medication changes between echo and catheterization * Written informed consent provided Exclusion Criteria: * Mitral stenosis or mitral annular calcification causing severe functional stenosis * Severe mitral or severe tricuspid regurgitation * Prosthetic mitral valve * Atrial fibrillation with rapid ventricular response \>120 bpm * Suboptimal echocardiographic imaging * Conditions rendering PCWP or LVEDP unreliable * Pregnant women * Complex congenital heart disease * LV assist device and patients with severe non-cardiac disease with poor prognosis * Cardiac transplant patients * End-stage liver disease
Study design
Enrollment target: 400 participants
Age groups: adult, older_adult
Timeline
Starts: 2026-09
Estimated completion: 2029-12
Last updated: 2026-09-10
Primary outcomes
  • • Diagnostic accuracy of a non-invasive algorithm for classification of left ventricular filling pressure in atrial fibrillation (• Start recruitment: February 2026 • End recruitment: January 2028 • Follow-up: 3 years • Data analysis: Ferbuary 2026 - December 2028. Outcome analysis will be extended to 3 years of follow-up. • Manuscript preparation: December 2028 - December 2029)
  • • Imaging markers associated with mortality and heart-failure hospitalization in atrial fibrillation (• Start recruitment: February 2026 • End recruitment: January 2028 • Follow-up: 3 years • Data analysis: Ferbuary 2026 - December 2028. Outcome analysis will be extended to 3 years of follow-up. • Manuscript preparation: December 2028 - December 2029)
Sponsor
Oslo University Hospital · other
With: The National Association for Public Health, Norway
Contacts & investigators
ContactLars-Egil Reine Hammersboen, Medical doctor · contact · lerhammersboen@gmail.com · +4790116941
ContactOtto Armin Smiseth, Professor, Medical Doctor · contact · otto.smiseth@gmail.com · +4790867189
InvestigatorOtto Armin Smiseth, Professor, Medical Doctor · study_chair, Oslo University Hospital
InvestigatorThor Edvardsen, Professor, Medical Doctor · study_director, Oslo University Hospital
All locations (15)
Cleveland ClinicNot Yet Recruiting
Cleveland, Ohio, United States
Methodist DeBakey Heart and Vascular CenterNot Yet Recruiting
Houston, Texas, United States
Cardiovascular Center Aalst, OLV Clinic, Aalst, BelgiumNot Yet Recruiting
Aalst, Belgium
Catholic University of LeuvenNot Yet Recruiting
Leuven, Belgium
Laboratory Signal Processing and Image, Department of CardiologyNot Yet Recruiting
Rennes, France
Service de Cardiologie, Hôpitaux Universitaires de StrasbourgNot Yet Recruiting
Strasbourg, France
Nagoya City University Graduate School of Medical SciencesNot Yet Recruiting
Nagoya, Aichi-ken, Japan
Ehime UniversityNot Yet Recruiting
Tōon, Ehime, Japan
University of AucklandNot Yet Recruiting
Auckland, Auckland, New Zealand
Division of Cardiovascular & Pulmonary Diseases, Oslo University HospitalRecruiting
Oslo, Oslo, Norway
Carol Davila University of Medicine and PharmacyNot Yet Recruiting
Bucharest, Romania
The Department of Cardiology at the Ljubljana University Medical CentreNot Yet Recruiting
Ljubljana, Slovenia
Yonsei University College of MedicineNot Yet Recruiting
Seoul, Seoul, South Korea
Department of Cardiovascular Sciences, University of BirminghamNot Yet Recruiting
Birmingham, United Kingdom
King's CollegeNot Yet Recruiting
London, United Kingdom
Novel Technologies to Improve Echocardiographic Estimates of Left Ventricular Filling Pressure in Heart Failure Combined With Atrial Fibrillation · TrialPath